In non-small cell lung cancer, CYR61 overexpression remarkably inhibited the proliferation of cancer cells by arresting them in G1 phase, prominently upregulated the expression of p53 and p21 (WAF1), and decreased the activity of cyclin-dependent kinase 2 [41]. Here, CDKN1A is linked to cancer.